Evidence map›Paper›PMID 39445817›Full record

ArticleAntimicrobial agents and chemotherapy2024

Therapeutic effect of topical tamoxifen in murine cutaneous leishmaniasis caused by

Parastoo Hassani-Abharian, Seyedamirmehdi Hejazi Dehaghani, Zabihollah Shahmoradi, Seyed Hossein Hejazi

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Parastoo Hassani-AbharianSkin Diseases and Leishmaniasis Research Center, Department of Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID 0000-0001-5728-1796
Seyedamirmehdi Hejazi DehaghaniSchool of Medicine, Padova University, Padova, Italy.
Zabihollah ShahmoradiSkin Diseases and Leishmaniasis Research Center, Department of Dermatology, Isfahan University of Medical Sciences, Isfahan, Iran.
Seyed Hossein HejaziSkin Diseases and Leishmaniasis Research Center, Department of Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID 0000-0002-3733-1220

Funding

Deputy of Research and Technology of the Isfahan University of Medical Sciences 298251
6 · The paper itself

Abstract

Iran is one of the endemic regions of cutaneous leishmaniasis (CL) caused by

Indexed as

Administration, TopicalLeishmania majorLeishmaniasis, CutaneousMice, Inbred BALB CTamoxifenAnimalsAntiprotozoal AgentsFemaleMiceAntiprotozoal AgentsTamoxifencutaneous leishmaniasisLeishmania majortamoxifen

Identifiers

PMID39445817
PMCPMC11619401

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.